Relationship of hypertriglyceridemia to atherosclerosis

Abstract

Dr. Robert Levy concluded the Workshop by summarizing the advantages and limitations of each of the major approaches addressed by the Workshop - the epidemiological, basic research and clinical research studies. He also discussed the limitations of our current knowledge from both the research and public health aspects relating hypertriglyceridemia and CHD. He concluded that, although the evidence suggesting hypertriglyceridemia as an independent risk factor in CHD was still in some doubt, hypertriglyceridemia is a marker for other disorders directly related to CHD. Dr. Lippel gave brief closing remarks.